Use of Eltrombopag in Improving Poor Graft Function after Allogeneic Hematopoietic Stem Cell Transplantation

Eltrombopag is a thrombopoietin agonist and has been used in aplastic anemia and post-transplantation thrombocytopenia. The c-MPL receptor is present on hematopoietic stem cells. There are no reports of eltrombopag utilization for improving poor graft function in the post-transplant setting. Here we...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Case Rep Oncol
Main Authors: Master, Samip, Dwary, Ashish, Mansour, Richard, Mills, Glenn M., Koshy, Nebu
Format: Artigo
Sprog:Inglês
Udgivet: S. Karger AG 2018
Fag:
Case Report
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5903126/
https://ncbi.nlm.nih.gov/pubmed/29681820
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000487229
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker